Evidence map›Paper›PMID 34390436›Full record

Trial reportInternational urology and nephrology2021

Evaluation of pedometer use in men with lower urinary tract symptoms: a randomized clinical trial.

Lucas Cortes Machado Agostini, Christiano Silva Brum, Humberto Elias Lopes, José Murillo Bastos Netto, André Avarese Figueiredo

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in International urology and nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lucas Cortes Machado AgostiniNIPU - Núcleo Interdisciplnar de Pesquisa em Urologia, Federal University of Juiz de Fora, Avenida Barão do Rio Branco, 5141, Apto 1606, Juiz de Fora, MG, 36026-500, Brazil.
Christiano Silva BrumNIPU - Núcleo Interdisciplnar de Pesquisa em Urologia, Federal University of Juiz de Fora, Avenida Barão do Rio Branco, 5141, Apto 1606, Juiz de Fora, MG, 36026-500, Brazil.
Humberto Elias LopesNIPU - Núcleo Interdisciplnar de Pesquisa em Urologia, Federal University of Juiz de Fora, Avenida Barão do Rio Branco, 5141, Apto 1606, Juiz de Fora, MG, 36026-500, Brazil.
José Murillo Bastos NettoNIPU - Núcleo Interdisciplnar de Pesquisa em Urologia, Federal University of Juiz de Fora, Avenida Barão do Rio Branco, 5141, Apto 1606, Juiz de Fora, MG, 36026-500, Brazil.
André Avarese FigueiredoNIPU - Núcleo Interdisciplnar de Pesquisa em Urologia, Federal University of Juiz de Fora, Avenida Barão do Rio Branco, 5141, Apto 1606, Juiz de Fora, MG, 36026-500, Brazil. andreavaresef@gmail.com.ORCID http://orcid.org/0000-0001-8732-2771
Universidade Federal de Juiz de Fora · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess the effect of a pedometer use in men aged between 50 and 59 years presenting lower urinary tract symptoms (LUTS).

methodsA single-center, not blind clinical trial with two parallel groups and equal randomization was performed with 38 men aged 50-59 years with LUTS. All patients received guidance and encouragement to physical activity practice. Only the intervention group received a Pedometer with a goal of 10,000 steps/day. After a period of 12 weeks, the groups were compared through the following variables: number of steps/day, IPSS score, flexibility, anthropometric values and Maximum Oxygen Consumption (VO2max).

resultsThe number of steps per day in the intervention group was 9753 ± 1549 compared to 6212 ± 1152 in the control group (p = 0.004). Pedometer use efficacy was a 50% risk reduction of not achieve the goal of 10,000 steps per day. Regarding IPSS score, the intervention group achieved lower scores (6.95 ± 2.85 vs. 10.16 ± 3.23, p = 0.007). Pedometer use efficacy was a 94% risk reduction of not achieve more than 30% reduction in IPSS score. In VO2max, the intervention group performed better than the control group (34.84 ± 3.25 vs. 32.58 ± 6.89; p = 0.011). There was no difference in flexibility and anthropometric values between the groups.

conclusionsThe use of pedometer in LUTS patients provided an increase in the number of steps/day, a decrease in LUTS score and an improvement in VO2max measure. CLINICAL

trial registrationTrial url: www.ensaiosclinicos.gov.br/rg/RBR-4vynk5/ . Register Number: RBR-4vynk5 .

Indexed as

ActigraphyExerciseHumansLower Urinary Tract SymptomsMaleMiddle AgedPatient ComplianceClinical trialExerciseLower urinary tract symptomsPedometerUrology

Identifiers

PMID34390436
OpenAlexW3192859897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.